CN Patent

CN111484489A — 无定形的b-raf激酶二聚体抑制剂

Assigned to Baiji Shenzhou Beijing Biotechnology Co ltd · Expires 2020-08-04 · 6y expired

What this patent protects

本发明涉及B‑RAF激酶二聚体抑制剂1‑((1S,1aS,6bS)‑5‑((7‑氧代‑5,6,7,8‑四氢‑1,8‑二氮杂萘‑4‑基)氧基)‑1a,6b‑二氢‑1H‑环丙并[b]苯并呋喃‑1‑基)‑3‑(2,4,5‑三氟苯基)脲(以下有时称为化合物1)的一种稳定无定形形式，所述无定形化合物的制备方法和所述无定形化合物的治疗用途。

USPTO Abstract

本发明涉及B‑RAF激酶二聚体抑制剂1‑((1S,1aS,6bS)‑5‑((7‑氧代‑5,6,7,8‑四氢‑1,8‑二氮杂萘‑4‑基)氧基)‑1a,6b‑二氢‑1H‑环丙并[b]苯并呋喃‑1‑基)‑3‑(2,4,5‑三氟苯基)脲(以下有时称为化合物1)的一种稳定无定形形式，所述无定形化合物的制备方法和所述无定形化合物的治疗用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN111484489A
Jurisdiction
CN
Classification
—
Expires
2020-08-04
Drug substance claim
No
Drug product claim
No
Assignee
Baiji Shenzhou Beijing Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.